Syndax to Present at the 2018 American Association for Cancer Research Annual Meeting

WALTHAM, Mass., April 13, 2018 /PRNewswire/ — Syndax Pharmaceuticals, Inc. (“Syndax,” the “Company” or “we”) (Nasdaq:SNDX), a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced twelve oral and poster presentations at the…

Share this post